Amyloid β peptide specifically promotes phosphorylation and nuclear translocation of the extracellular signal-regulated kinase in cultured rat cortical astrocytes

Journal of Pharmacological Sciences

Volumn 93, Issue 3, 2003, Pages 272-278

  Abe, Kazuho ^a   Hisatomi, Rie ^a   Misawa, Miwa ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Amyloid protein; Astrocyte; Extracellular signal regulated kinase; Nuclear translocation; Tyrosine phosphorylation

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; AMYLOID BETA PROTEIN; ENZYME ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE 1; SYNAPTOPHYSIN; THREONINE; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL COUNT; CELL CULTURE; CELL NUCLEUS; CONTROLLED STUDY; CYTOSOL; ENZYME LOCALIZATION; ENZYME PHOSPHORYLATION; ENZYME REGULATION; ENZYME RELEASE; EXTRACELLULAR SPACE; IMMUNOFLUORESCENCE TEST; INHIBITION KINETICS; NONHUMAN; OUTCOMES RESEARCH; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; WESTERN BLOTTING;

AMYLOID BETA-PROTEIN; ANIMALS; ASTROCYTES; CELL NUCLEUS; CELLS, CULTURED; CEREBRAL CORTEX; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RATS; RATS, WISTAR;

EID: 0346245130     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.93.272     Document Type: Article

References (24)

1. Yankner BA, Duffy LK, Kirschner DA. Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides. Science. 1990;25:279-282.
2. Pike CJ, Walencewicz AJ, Glabe CG, Cotman CW. In vivo aging of β-amyloid protein causes peptide aggregation and neurotoxicity. Brain Res. 1991;563:311-314.
3. Mattson MP, Tomaselli KJ, Rydel RE. Calcium-destabilization and neurodegenerative effects of aggregated β-amyloid peptide are attenuated by basic FGF. Brain Res. 1993;621:35-49.
4. Behl C, Davis JB, Lesley R, Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell. 1994;77:817-827.
5. Dickson DW, Farlo J, Davies P, Crystal H, Fuld P, Yen SC. A double-labeling immunohistochemical study of senile plaques. Am J Pathol. 1988;132:86-101.
6. Duffy PE, Rapport M, Graf L. Glial fibrillary acidic protein and Alzheimer-type senile dimentia. Neurology. 1990;30:778-782.
7. Mandybur TI, Chuirazzi CC. Astrocytes and the plaques of Alzheimer's disease. Neurology. 1990;40:635-639.
8. Pike CJ, Cummings BJ, Monzavi R, Cotman CW. β-Amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease. Neuroscience. 1994;63:517-531.
9. Patel AJ, Gunasekera S, Jen A, Rohande Silva HA. β-Amyloid-mediated inhibition of redox activity (MTT reduction) is not an indicator of astroglial degeneration. Neuroreport. 1996;7:2026-2030.
10. Kato M, Saito H, Abe K. Nanomolar amyloid β protein-induced inhibition of cellular redox activity in cultured astrocytes. J Neurochem. 1997;68:1889-1895.
11. Hu J, Akama KT, Kraft GA, Chromy BA, Van Eldik LJ. Amyloid-β peptide activates cultured astrocytes: Morphological alterations, cytokine induction and nitric oxide release. Brain Res. 1998;785:195-206.
12. Bales KR, Du Y, Dodel RC, Yan GM, Hamilton-Byrd E, Paul SM. The NF-κB/Rel family of proteins mediates Aβ-induced neurotoxicity and glial activation. Mol Brain Res. 1998;57:63-72.
13. Abe K, Misawa M. Amyloid β protein enhances the clearance of extracellular L-glutamate by cultured rat cortical astrocytes. Neurosci Res. 2003;45:25-31.
14. Canning DR, McKeon RJ, DeWitt DA, Perry G, Wujek JR, Frederickson RCA, Silver J. β-Amyloid of Alzheimer's disease induces reactive gliosis that inhibits axonal growth. Exp Neurol. 1993;124:289-298.
15. Abe K, Kato M, Saito H. Human amylin mimics amyloid β protein-induced reactive gliosis and inhibition of cellular redox activity in cultured astrocytes. Brain Res. 1997;762:285-288.
16. Lewis TS, Shapiro PS, Ahn NG. Signal transduction through MAP kinase cascades. Adv Cancer Res. 1998;74:49-139.
17. Seger R, Krebs EG. The MAPK signaling cascade. FASEB J. 1995;9:726-735.
18. Sugden PH, Clerk A. Regulation of the ERK subgroup of MAP kinase cascades through G protein-coupled receptors. Cell Signal. 1997;9:337-351.
19. Ferrell JE, Bhatt RR. Mechanistic studies of the dual phosphorylation of mitogen-activated protein kinase. J Biol Chem. 1997;272:19008-19016.
20. Burack WR, Sturgill TW. The activating dual phosphorylation of MAPK by MEK is nonprocessive. Biochemistry. 1997;36:5929-5933.
21. Abe K, Saito H. Adenosine stimulates stellation of cultured rat cortical astrocytes. Brain Res. 1998;804:63-71.
22. Keyse SM. An emerging family of dual specificity MAP kinase phosphatases. Biochim Biophys Acta. 1995;1265:152-160.
23. Alessi DR, Gomez N, Moorhead G, Lewis T, Keyse SM, Cohen P. Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase, but not CL100, in various cell lines. Curr Biol. 1995;5:283-295.
24. Zhao Z, Tan A, Diltz CD, You M, Fischer H. Activation of mitogen-activated protein (MAP) kinase by pervanadate, a potent inhibitor of tyrosine phosphatase. J Biol Chem. 1996;36:22251-22255.